← Bioceres Crop Solutions Corp.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $133.5m |
$160.6m
+20.27%
|
$173.1m
+7.77%
|
$209.5m
+21.05%
|
$334.8m
+59.79%
|
$415.7m
+24.16%
|
$464.8m
+11.81%
|
$335.1m
-27.90%
|
$293.7m
-12.37%
|
|
| Revenues from contracts with customers | $133.5m | $160.3m | $172.4m | $206.7m | $328.5m | $419.4m | $464.8m | $333.3m | — | |
| Cost of Goods and Services Sold | $77.1m |
$87.0m
+12.80%
|
$93.6m
+7.60%
|
$118.6m
+26.79%
|
$208.4m
+75.62%
|
$235.5m
+13.00%
|
$278.2m
+18.16%
|
$203.4m
-26.88%
|
$181.1m
-10.99%
|
|
| Cost of sales | ($77.1m) |
($87.0m)
-12.80%
|
($93.6m)
-7.60%
|
($118.6m)
-26.79%
|
($208.4m)
-75.62%
|
($235.5m)
-13.00%
|
($278.2m)
-18.16%
|
($203.4m)
+26.88%
|
$181.1m
+189.01%
|
|
| Gross Profit | $56.4m |
$73.6m
+30.46%
|
$79.5m
+7.98%
|
$90.9m
+14.30%
|
$126.4m
+39.12%
|
$180.2m
+42.56%
|
$186.6m
+3.50%
|
$131.7m
-29.42%
|
$112.6m
-14.49%
|
|
| Research And Development Expense | $4.0m | $3.7m | $4.2m | $5.6m | $6.9m | $15.3m | $17.2m | $14.9m | $16.6m | |
| Selling, General and Administrative Expense | $35.3m | $39.2m | $38.3m | $47.6m | $77.5m | $113.0m | $123.7m | $123.1m | $79.3m | |
| Other Operating Income Expense | $613k | $366k | ($307k) | ($279k) | ($3.3m) | $1.1m | ($2.5m) | $6.8m | — | |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | ($2.1m) | $1.0m | $2.5m | $997k | $1.1m | $1.2m | $4.0m | ($1.1m) | — | |
| Other income or expenses, net | $613k | $366k | ($307k) | ($279k) | ($3.3m) | $1.1m | ($2.5m) | $6.8m | — | |
| Current Tax Expense (Income) | — | $2.1m | $4.1m | $10.1m | $19.0m | $1.3m | $8.9m | $1.4m | — | |
| Deferred Tax Expense (Income) | — | $4.8m | ($1.9m) | $4.3m | ($1.0m) | ($2.4m) | ($5.1m) | ($135k) | — | |
| (Loss)/ Profit before income tax | ($25.2m) | ($9.4m) | $6.4m | $10.5m | $14.1m | $19.1m | $10.0m | ($57.6m) | — | |
| Income tax | $10.9m | ($7.0m) | ($2.2m) | ($14.4m) | ($18.0m) | $1.1m | ($3.8m) | ($1.3m) | $7.1m | |
| Basic Earnings (Loss) Per Share | — | ($0.60) | $0.09 | ($0.18) | ($0.17) | $0.30 | $0.05 | ($0.88) | ($3.78) | |
| Diluted Earnings (Loss) Per Share | ($0) | ($1) | $0.09 | ($0.18) | ($0.17) | $0.30 | $0.05 | ($0.88) | ($3.78) | |
| Additional Financial Items | ||||||||||
| Administrative Expense | — | $384k | $359k | $681k | — | — | — | — | — | |
| Applicable Tax Rate | — | $0 | — | $0 | — | — | — | — | — | |
| Depreciation Right of Use Assets | — | — | $567k | $827k | $1.3m | $3.6m | $3.4m | $5.0m | $10.0m | |
| Expense From Share-Based Payment Transactions With Employees | — | $20.9m | — | — | — | — | — | — | — | |
| Finance Costs | — | $26.1m | $20.9m | $21.2m | $17.9m | $23.8m | $26.9m | $28.8m | — | |
| Finance Income | — | $8.7m | — | — | — | — | — | — | — | |
| Professional Fees Expense | — | $8.0m | $3.3m | $8.5m | $9.3m | $16.1m | $10.7m | $11.3m | — | |
| Profit Loss Attributable To Noncontrolling Interests | — | $2.0m | $877k | $3.0m | $3.3m | $1.4m | $3.0m | ($3.4m) | — | |
| Profit Loss Attributable To Owners Of Parent | — | ($18.4m) | $3.4m | ($6.9m) | ($7.2m) | $18.8m | $3.2m | ($55.4m) | — | |
| Profit Loss Before Tax | $25.2m | ($9.4m) | $6.4m | $10.5m | $14.1m | $19.1m | $10.0m | ($57.6m) | — | |
| Profit Loss From Operating Activities | $15.7m | $32.1m | $39.1m | $38.4m | $39.9m | $54.2m | $44.8m | ($2.2m) | — | |
| Initial recognition and changes in the fair value of biological assets at the point of harvest | — | $280k | $717k | $2.8m | $6.4m | $611k | ($46k) | $1.8m | — | |
| Changes in the net realizable value of agricultural products after harvest | — | — | — | — | ($43k) | ($4.4m) | ($2.4m) | ($1.5m) | — | |
| Share of profit or loss of joint ventures and associates | ($2.1m) | $1.0m | $2.5m | $997k | $1.1m | $1.2m | $4.0m | ($1.1m) | — | |
| Operating (loss)/ profit | $15.7m | $32.1m | $39.1m | $38.4m | $39.9m | $54.2m | $44.8m | ($2.2m) | — | |
| Financial cost | ($17.2m) | ($24.4m) | ($20.9m) | ($21.2m) | ($17.9m) | ($23.8m) | ($26.9m) | ($28.8m) | — | |
| Other financial results | ($23.8m) | ($17.1m) | ($11.8m) | ($6.6m) | ($7.9m) | ($11.3m) | ($7.9m) | ($26.5m) | — | |
| (Loss)/ Profit for the year | ($14.3m) | ($16.4m) | $4.2m | ($3.8m) | ($3.9m) | $20.2m | $6.3m | ($58.8m) | — | |
| Equity holders of the parent | ($33.9m) | ($14.3m) | ($5.2m) | $1.6m | $22.1m | $17.9m | $2.8m | ($56.0m) | — | |
| Non-controlling interests | ($12.2m) | $1.9m | ($223k) | $4.7m | $9.1m | $1.4m | $2.7m | ($3.6m) | — | |
| Basic loss attributable to ordinary equity holders of the parent | — | ($0.60) | $0.09 | ($0) | ($0) | $0 | $0 | ($1) | — | |
| Diluted loss attributable to ordinary equity holders of the parent | ($0) | ($1) | $0 | ($0) | ($0) | $0 | $0 | ($1) | — | |
| Other comprehensive (loss) | ($31.8m) | $3.9m | ($9.7m) | $10.1m | $35.2m | ($836k) | ($787k) | ($714k) | — | |
| Items that may be subsequently reclassified to (loss)/ profit | ($43.7m) | $5.3m | ($13.6m) | $12.7m | $40.5m | $632k | ($787k) | ($714k) | — | |
| Foreign exchange differences on translation of foreign operations from joint ventures | ($13.9m) | $11k | ($3.5m) | $2.7m | $7.8m | ($47k) | ($238) | — | — | |
| Foreign exchange differences on translation of foreign operations | ($29.8m) | $5.2m | ($10.1m) | $10.1m | $32.6m | $678k | ($787k) | ($714k) | — | |
| Items that will not be subsequently reclassified to loss and profit | $11.9m | ($1.3m) | $3.9m | ($2.7m) | ($5.3m) | ($1.5m) | — | — | — | |
| Revaluation of property, plant and equipment, net of tax, of joint ventures and associates 1 | $1.8m | ($1.4m) | $3.4m | ($2.3m) | ($4.7m) | ($1.3m) | — | — | — | |
| Total comprehensive (loss)/ profit | ($46.1m) | ($12.5m) | ($5.4m) | $6.2m | $31.3m | $19.3m | $5.5m | ($59.6m) | — |